[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nuwellis Inc (NUWE)

Nuwellis Inc (NUWE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 365
  • Shares Outstanding, K 2,681
  • Annual Sales, $ 8,270 K
  • Annual Income, $ -17,520 K
  • EBIT $ -13 M
  • EBITDA $ -12 M
  • 60-Month Beta 0.19
  • Price/Sales 0.05
  • Price/Cash Flow N/A
  • Price/Book 0.13
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -64.02
  • Most Recent Earnings $-2.09 on 05/12/26
  • Next Earnings Date 08/13/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Instruments

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $73.11
  • Growth Rate Est. (year over year) +1,266.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1246 +8.35%
on 06/16/26
1.0500 -87.14%
on 05/22/26
-0.8600 (-86.43%)
since 05/15/26
3-Month
0.1246 +8.35%
on 06/16/26
1.2800 -89.45%
on 04/14/26
-1.0450 (-88.56%)
since 03/16/26
52-Week
0.1246 +8.35%
on 06/16/26
25.9500 -99.48%
on 07/16/25
-11.6208 (-98.85%)
since 06/16/25

Most Recent Stories

More News
Nuwellis Appoints Mike McCormick as Chief Executive Officer

MINNEAPOLIS, June 16, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces the appointment...

NUWE : 0.1350 (-0.88%)
Nuwellis Expands Collaboration with Major South Carolina Healthcare System to Install New Aquadex SmartFlow® Devices at One of its Children’s Hospitals

MINNEAPOLIS, June 10, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announces...

NUWE : 0.1350 (-0.88%)
Nuwellis Announces Closing of $6.0 Million Registered Public Offering 

MINNEAPOLIS , June 08, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announces...

NUWE : 0.1350 (-0.88%)
Nuwellis Announces Pricing of $6 Million Public Offering

MINNEAPOLIS, June 05, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announces...

NUWE : 0.1350 (-0.88%)
Nuwellis Announces Successful Completion of FDA Pre-Submission 510(k) Meeting to Expand Aquadex Label

MINNEAPOLIS, May 14, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announces the...

NUWE : 0.1350 (-0.88%)
Nuwellis, Inc. Announces First Quarter 2026 Financial Results

MINNEAPOLIS, May 12, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today reported financial...

NUWE : 0.1350 (-0.88%)
Nuwellis, Inc. To Announce First Quarter 2026 Financial Results on May 12, 2026

MINNEAPOLIS, May 05, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces it will...

NUWE : 0.1350 (-0.88%)
Nuwellis Highlights Case Study Featuring Precision Ultrafiltration Therapy in Pediatric Cardiorenal Care at ISHLT 2026 Annual Meeting

MINNEAPOLIS, April 29, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, highlights a case...

NUWE : 0.1350 (-0.88%)
Nuwellis Announces Receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for Innovative Dual Lumen Midline Catheter Technology

MINNEAPOLIS, April 28, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces that...

NUWE : 0.1350 (-0.88%)
Nuwellis to Participate in the AATS 106th Annual Meeting and ERAS Cardiac Spring Retreat

MINNEAPOLIS, April 23, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces it will...

NUWE : 0.1350 (-0.88%)

Business Summary

Nuwellis Inc. is a medical device company. It is focused on developing, manufacturing and commercializing the Aquadex SmartFlow(R) System for ultrafiltration therapy. Nuwellis Inc., formerly known as CHF Solutions, is headquartered in Minneapolis, Minn.

See More

Key Turning Points

3rd Resistance Point 0.1489
2nd Resistance Point 0.1419
1st Resistance Point 0.1385
Last Price 0.1350
1st Support Level 0.1281
2nd Support Level 0.1211
3rd Support Level 0.1177

See More

52-Week High 25.9500
Fibonacci 61.8% 16.0847
Fibonacci 50% 13.0373
Fibonacci 38.2% 9.9899
Last Price 0.1350
52-Week Low 0.1246

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.